This case tests profitability analysis and market opportunity assessment for a healthcare PE investment. The key insight is recognizing that declining EBITDA margins in 2023 are caused by temporary fixed costs from launching x-rays (a higher-margin service), not operational deterioration, which actually supports the investment thesis. Candidates must balance quantitative financial analysis with strategic judgment about service expansion and competitive positioning.